(Q34310177)

1 August 2017

1 reference

title

Cholecystokinin/dopamine/GABA interactions in the nucleus accumbens: biochemical and functional correlates (English)

1 reference

1 August 2017

1 reference

1 reference

2

Fuxe K

1 reference

1 August 2017

Tanganelli S

1

1 reference

1 August 2017

Antonelli T

series ordinal

3

1 reference

1 August 2017

O'Connor WT

series ordinal

4

1 reference

1 August 2017

Ferraro L

series ordinal

5

1 reference

1 August 2017

publication date

1 August 2001

1 reference

1 August 2017

1 reference

1 August 2017

volume

22

1 reference

1 August 2017

issue

8

1 reference

1 August 2017

page(s)

1229-1234

1 reference

Neurotensin in vitro markedly reduces the affinity in subcortical limbic 3H-N-propylnorapomorphine binding sites

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900446-6

7 January 2021

The role of CCK caerulein, and CCK antagonists in nociception

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900446-6

7 January 2021

Amphetamine lowers extracellular GABA concentration in the ventral pallidum.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900446-6

7 January 2021

Two faces of cholecystokinin: anxiety and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900446-6

7 January 2021

Cholecystokinin-dopamine interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900446-6

7 January 2021

Subtype-selective cholecystokinin receptor antagonists block cholecystokinin modulation of dopamine-mediated behaviors in the rat mesolimbic pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900446-6

7 January 2021

Biological actions of cholecystokinin

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900446-6

7 January 2021

Regulation of dopamine D2 receptor affinity by cholecystokinin octapeptide in fibroblast cells cotransfected with human CCKB and D2L receptor cDNAs

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900446-6

7 January 2021

CCK in anxiety and cognitive processes.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900446-6

7 January 2021

Isolation, structure and biological activity of two cholecystokinin octapeptides from sheep brain

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900446-6

7 January 2021

Cholecystokinin octapeptide: Vesicular localization and calcium dependent release from rat brain in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900446-6

7 January 2021

Evidence for a differential cholecystokinin-B and -A receptor regulation of GABA release in the rat nucleus accumbens mediated via dopaminergic and cholinergic mechanisms.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900446-6

7 January 2021

CCK in animal and human research on anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900446-6

7 January 2021

Cholecystokinin receptors in brain: Effects of obesity, drug treatment, and lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900446-6

7 January 2021

Evidence for coexistence of dopamine and CCK in meso-limbic neurones

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900446-6

7 January 2021

A subpopulation of mesencephalic dopamine neurons projecting to limbic areas contains a cholecystokinin-like peptide: evidence from immunohistochemistry combined with retrograde tracing

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900446-6

7 January 2021

Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900446-6

7 January 2021

Striatal interneurones: chemical, physiological and morphological characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900446-6

7 January 2021

Cholecystokinin (CCK) increases GABA release in the rat anterior nucleus accumbens via CCK(B) receptors located on glutamatergic interneurons

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900446-6

7 January 2021

Cholecystokinin octapeptide in vitro and ex vivo strongly modulates striatal dopamine D2 receptors in rat forebrain sections

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900446-6

7 January 2021

Cholecystokinin modulates the release of dopamine from the anterior and posterior nucleus accumbens by two different mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900446-6

7 January 2021

Cholecystokinin in anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900446-6

7 January 2021

Two brain cholecystokinin receptors: implications for behavioral actions

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900446-6

7 January 2021

CCK-B receptor: chemistry, molecular biology, biochemistry and pharmacology

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900446-6

7 January 2021

Cholecystokinin and panic disorder--three unsettled questions

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900446-6

7 January 2021

Molecular forms of cholecystokinin in the brain and the relationship to neuronal gastrins

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900446-6

7 January 2021

Nucleus accumbens dopamine-CCK interactions in psychostimulant reward and related behaviors

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900446-6

7 January 2021

New peptide in the vertebrate CNS reacting with antigastrin antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900446-6

7 January 2021

10.1016/S0196-9781(01)00446-6

Identifiers

DOI

1 reference

1 August 2017

1 reference